Pernix therapeutics holdings, inc. (PTX)
Income statement / Quarterly
Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Net revenues

37,156

21,088

-

-

40,469

34,316

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net revenues

-

-

28,139

-

-

-

29,742

30,173

41,468

36,746

32,469

46,369

48,615

46,977

33,889

53,834

31,479

17,382

19,052

23,925

18,295

20,573

22,077

-

18,134

10,499

-

-

-

-

-

-

-

Gross profit

-

-

-

-

-

-

-

-

-

-

-

-

-

33,183

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Costs and operating expenses:
Cost of product sales

11,823

5,569

8,961

-

10,580

10,493

10,040

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14,482

-

17,064

12,044

10,094

7,753

4,328

Cost of product sales

-

-

-

-

-

-

-

9,048

10,840

12,194

11,238

13,982

12,036

13,794

11,596

15,965

12,664

9,380

9,956

10,058

9,572

11,162

13,077

7,515

7,759

3,411

4,690

7,852

7,684

3,428

1,956

1,410

674

Selling, general and administrative expense

31,872

18,257

17,283

17,282

20,226

19,018

20,275

25,219

22,173

25,492

25,950

24,679

27,419

24,857

20,466

19,233

14,080

13,222

13,623

23,590

11,740

13,141

14,079

11,149

9,837

7,636

6,829

6,602

5,542

4,793

5,219

3,505

2,787

Research and development expense

1,524

6

4

78

99

82

528

940

1,712

2,499

928

2,585

3,180

1,470

994

2,334

290

345

969

1,165

633

1,792

1,207

220

332

108

70

204

147

464

106

252

315

Loss on sale of PML (including impairment charge)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-13

215

6,457

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Loss from the operations of the joint venture with SEEK

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

240

-

100

261

330

0

0

Royalties expense, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

32

83

261

205

0

Depreciation and amortization expense

2,391

1,430

9,865

18,240

18,214

18,215

18,547

20,712

20,700

21,062

23,664

28,203

25,733

22,326

18,433

18,680

10,159

1,969

2,191

2,257

2,317

2,276

1,824

880

885

796

638

612

603

594

493

300

190

Change in fair value of contingent consideration

-

-

-

-

-

-

-

-

-516

3,972

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of contingent consideration

0

-120

263

-1,389

884

-886

346

-

-

-

-5,502

3,458

-3,596

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from disposal and impairments of assets

75

-

-

-

25

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from disposal and impairments of assets

-

-

-

-

-

-

-

-

-652

-1,771

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

Gain from legal settlement

0

-

-

-

10,476

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring costs

-2

385

829

54

-97

31

100

10

2,277

0

0

-56

-4

-108

1,305

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of assets held for sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Total costs and operating expenses

47,683

25,527

37,205

66,283

39,455

46,953

49,836

106,990

58,870

59,046

56,278

110,997

64,768

48,545

52,794

56,454

37,180

25,131

33,196

55,903

24,258

28,377

30,188

19,765

18,815

11,952

12,467

15,396

14,110

9,625

8,366

5,673

3,968

Income (loss) from operations

-10,527

-4,439

-9,066

-24,742

1,014

-12,637

-20,094

-76,817

-17,402

-22,300

-23,809

-50,834

-16,153

-15,362

-18,905

-2,620

-5,701

-7,749

-14,144

-31,977

-5,963

-7,804

-8,110

-1,568

-681

-1,453

2,014

6,006

2,953

2,419

1,728

2,079

359

Other income (expense):
Interest income

-

-

-

-

-

-

-

-

-

-

-

4

43

54

56

43

118

100

92

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

10,073

9,530

9,460

-

9,323

9,209

8,959

-

8,857

8,937

9,024

9,459

9,687

9,733

9,398

10,007

5,453

2,334

1,356

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of assets

0

446

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

-4

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of derivative liability

18

40

-19

85

46

270

-354

2,191

-209

159

6,794

85

10,527

8,703

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain from exchange of debt

137

-

-

-

14,650

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency transaction gain

-843

-21

-

-

0

0

-

1

31

-71

138

-582

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of put right

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-10,196

2,146

1,830

-2,140

-

-

0

0

-

-

-

-

-

-

Change in fair value of contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-522

0

283

-

-

0

0

-

-

-

-

-

-

Other expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

277

0

Gain from bargain purchase

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

881

-

Interest expense, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-783

-1,632

-1,076

-35

7

-27

-39

-41

-37

-62

-30

8

4

Gain on sale of investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

3,605

-

-

-

0

-

-

-

-

-

-

-

Cost of inducement

-

-

-

-

-

-

-

-

-

-

-

-

0

-19,500

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-1,112

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other expense, net

-10,761

-9,065

-9,479

-7,430

5,373

-8,939

-9,313

-8,847

-9,035

-8,849

-2,092

-9,952

-229

-20,476

-9,342

-9,964

-5,335

-2,234

-1,264

12,662

-2,407

142

-2,934

-35

7

-27

-39

-

-

-

-

-

-

Income (loss) before income tax expense

-21,288

-13,504

-18,545

-32,172

6,387

-21,576

-29,407

-85,664

-26,437

-31,149

-25,901

-60,786

-16,382

-35,838

-28,247

-12,584

-11,036

-9,983

-15,408

-19,315

-8,370

-7,661

-11,044

-1,603

-674

-1,480

1,974

-

-

-

-

-

-

Total other income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-30

1,168

5

Income (loss) before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,916

2,356

1,698

3,247

-

Income before income taxes and non-controlling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

364

Income tax expense

61

9

39

251

27

40

55

413

1

-10

35

20,880

-5,642

-3,603

-4,573

-4,765

655

-3,749

-5,866

-13,091

-2,547

-1,985

-3,134

-204

-404

-549

783

2,089

922

855

723

861

201

Net income (loss)

-21,349

-

-

-

6,360

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

163

Adjust: Net loss attributable to noncontrolling interests

-9,504

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3

Net income (loss) attributable to common stockholders

-11,845

-13,513

-18,584

-32,423

6,360

-21,616

-29,462

-86,077

-26,438

-31,139

-25,936

-81,666

-10,740

-32,235

-23,674

-7,819

-11,691

-6,234

-9,542

-6,224

-5,823

-5,676

-7,910

-1,399

-270

-931

1,191

3,876

1,994

1,501

975

2,385

166

Net income (loss) per common share attributable to common stockholders:
Unrealized gain during period, net of tax of $0 and $0, respectively

-

0

0

-

-

18

6

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized Gain (loss) during period, net of tax of $0 and $0, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

746

-1,448

-400

808

455

1,023

-

-

0

0

-

-

Reclassification adjustment for net gains included in net loss, net of tax of $0, $0 and ($1,332), respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

2,273

-

-

-

-

-

-

-

-

-

-

-

Comprehensive loss

-

-13,513

-18,584

-

-

-21,598

-29,456

-86,156

-26,438

-31,139

-25,936

-

-

-

-

-

-

-

-

-6,224

-5,823

-7,203

-9,359

-1,799

538

-476

2,214

4,965

1,994

1,501

975

-

-

Basic

-0.89

-1.13

-1.57

-2.68

0.57

-2.16

-2.94

-9.77

-2.99

-4.67

-4.24

-24.81

-1.76

-0.62

-0.62

-0.20

-0.31

-0.16

-0.26

-0.16

-0.16

-0.15

-0.23

-0.06

-0.01

-0.03

0.05

0.16

0.08

0.07

0.04

0.10

0.01

Diluted

-0.89

-1.13

-1.57

-2.53

0.42

-2.16

-2.94

-9.77

-2.99

-4.67

-4.24

-24.81

-1.76

-0.62

-0.62

-0.20

-0.31

-0.16

-0.26

-0.16

-0.16

-0.15

-0.23

-0.05

-0.01

-0.03

0.04

0.15

0.08

0.07

0.04

0.10

0.01

Weighted-average common shares outstanding:
Basic

13,301

11,913

11,869

11,675

11,117

10,016

10,016

9,685

8,842

6,669

6,112

-75,617

6,097

52,399

38,453

75,497

38,121

37,828

37

73,571

37

37,114

35,052

-83,168

29,069

28,291

25,921

25,770

24,841

22,698

22,652

24,389

24,557

Diluted

13,301

11,913

11,869

6,272

16,520

10,016

10,016

9,685

8,842

6,669

6,112

-75,617

6,097

52,399

38,453

75,497

38,121

37,828

37

73,571

37

37,114

35,052

-83,721

29,069

28,291

26,473

26,509

25,147

23,043

23,141

24,416

24,608